Search results
Results From The WOW.Com Content Network
Monica Lopez, a nurse at Children's Hospital Los Angeles, prepares to administer the Pfizer/BioNTech COVID-19 vaccine to 3-year-old Callum Diaz-Cheng during the hospital's first round of vaccines ...
LONDON (Reuters) -Pfizer and Moderna's legal battle over their rival COVID-19 vaccines looks set to continue after London's High Court gave a mixed ruling on two of Moderna's patents, likely ...
"It's OK to mix and match Moderna and Pfizer," Dr. Ralph Gonzales, associate dean for clinical innovation and chief innovation officer for UC San Francisco, said at a campus town hall last week.
The Moderna news followed preliminary results from the Pfizer-BioNTech vaccine candidate, BNT162b2, with Moderna demonstrating similar efficacy, but requiring storage at the temperature of a standard medical refrigerator of 2–8 °C (36–46 °F) for up to thirty days or −20 °C (−4 °F) for up to four months, whereas the Pfizer-BioNTech ...
Moderna, Inc. Moderna, Inc. ( / məˈdɜːrnə / mə-DUR-nə) [4] is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. These vaccines use a copy of a molecule called messenger RNA (mRNA) to carry instructions for proteins to produce an immune response.
Pfizer and BioNTech set their price at $120, and Moderna doses will be $129. Novavax shots will be $130 per dose. The vaccine is recommended for everyone six months and older.
mRNA-1283 is a COVID-19 vaccine candidate developed by Moderna. [ 2][ 3] Compared to prior mRNA vaccines, this candidate has a storage temperature of 2-5 °C, compatible with vaccine storage in a standard refrigerator, rather than low temperature freezers. [ 4] Additionally, the vaccine will be packaged in prefilled syringes, reducing burden on ...
Moderna, Pfizer/BioNTech and relative newcomer to the COVID vaccine market Novavax have created versions of their shots aimed at the XBB.1.5 subvariant, the dominant variant through most of 2023.